Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jun 13.
Published in final edited form as: J Womens Health (Larchmt). 2007 Jan-Feb;16(1):24–35. doi: 10.1089/jwh.2006.0071

Do Cervical Cancer Screening Rates Increase in Association with an Intervention Designed to Increase Mammography Usage?

MIRA L KATZ 1, CATHY M TATUM 2, CECILIA R DEGRAFFINREID 2, STEPHANIE DICKINSON 3, ELECTRA D PASKETT 1
PMCID: PMC4465268  NIHMSID: NIHMS694514  PMID: 17324094

Abstract

Objectives

To assess cervical cancer screening behaviors among underserved women participating in an intervention designed to increase mammography use.

Methods

This was a randomized trial of 897 women from three racial groups (white, African American, Native American) living in a rural county in North Carolina. Baseline and follow-up surveys were completed by 815 women; 775 women provided data to be included in these analyses. The intervention group received an educational program focused on mammography delivered by a lay health advisor, and the control group received a physician letter/brochure focusing on Pap tests.

Results

Women in both the intervention (OR 1.70; 1.31, 2.21, p < 0.001) and control groups (OR 1.38; 1.04, 1.82, p = 0.025) significantly increased cervical cancer screening rates within risk appropriate guidelines. No differences by racial group were documented. Women categorized in the high-risk group for developing cervical cancer (>2 sexual partners, age <18 years at first sexual intercourse, smoker; treated for sexually transmitted disease [STD] or partner with treated STD) significantly (OR 1.88; 1.54, 2.28, p < 0.001) increased Pap test completion. However, a nonsignificant increase (OR 1.25; 0.87, 1.79, p = 0.221) in Pap test completion was demonstrated in women categorized as low risk for cervical cancer.

Conclusions

This study suggests that women in an intensive behavioral intervention designed to increase mammography use may also increase Pap test completion, similar to a minimal intervention focused only on increasing Pap test completion. These results have implications for the design and evaluation of behavioral intervention studies.

INTRODUCTION

Interventions to Increase Cancer Screening have generally focused on increasing the rates of a disease-specific test (e.g., mammography for breast cancer). When behavioral interventions are designed to increase the rates of one screening test, the rates of use of different site-specific cancer screening tests are usually not monitored for changes. Additionally, interventions designed to change multiple cancer screening behaviors simultaneously,113 as well as interventions aimed at multiple risk factors (e.g., nutrition and physical activity, smoking and alcohol cessation),1422 have had varied success depending on the type of intervention or the behaviors being modified.

Acknowledging that health behaviors often cluster, the value of being able to simultaneously change multiple cancer screening behaviors with an intervention aimed at a specific cancer screening behavior has theoretical, study design, and cost implications. There is now interest in health behavior theory research that addresses multiple behaviors.23,24 To begin exploration of this potentially practical, yet complex behavioral relationship, we assessed the change in cervical cancer screening rates in underserved women participating in a randomized intervention designed exclusively to increase mammography screening.25,26

MATERIALS AND METHODS

Data for this study were obtained as part of the Robeson County Outreach Screening and Education (ROSE) Project.25,26 The ROSE Project was designed to improve breast cancer screening in medically underserved women living in North Carolina, and the design and methods have been reported previously.25 Using a randomized design, the ROSE Project evaluated the use of an individualized health education intervention delivered by a lay health advisor to increase mammography rates. In this report of cervical cancer screening rates, we used data from the baseline and follow-up (12–14 months later) surveys of the women participating in the ROSE project. This study was approved by the Institutional Review Boards of the Wake Forest University School of Medicine and The Ohio State University.

Setting

Robeson County is a large rural county located on the southeastern coastal plain of North Carolina.25 In 1996, when this study began, the county’s poverty rate was 24.7%, and the unemployment rate was 7.5%.27 Access to health care is limited in this county, which lacks a countywide public transportation system. As a result of these conditions, the morbidity and mortality rates in Robeson County are higher than the state average for many diseases. The population of Robeson County comprises three main racial groups: Native Americans (predominantly Lumbee Indians) (38%), African Americans (25%), and whites (33%). The remaining 4% of the county’s population comprises Hispanics and Asian/Pacific Islanders.

Study population

Robeson Health Care Corporation (RHCC) is one of the major healthcare providers in the county and has four federally funded sites through a Community Health Center program. In 1996, these four centers collectively served approximately 12,778 patients; 68% were female, approximately 63% of the users had incomes below the poverty level, one third had no health insurance, and 32% were covered by Medicaid.

In brief, women were randomly selected from a list of RHCC female patients older than 40 years, stratifying on clinic and race to ensure a balanced sample. A total of 897 women in need of a mammogram consented to participate in this project, completed the face-to-face baseline survey, and were randomized to the two groups (lay health advisor or the comparison group). The participation rate was 89%, and the process of random selection of these women has been reported previously.25 Participants were mailed a $10.00 grocery store gift certificate after completion of the baseline survey and were given a small gift after completion of the follow-up face-to-face survey (12–14 months later) in appreciation of their time.

Intervention design

Theoretical framework

The educational intervention was designed to address the specific barriers to mammography use by rural women. Several health behavior theories provided a framework for the one-to-one interactive educational program.2832 The PRECEDE-PROCEED MODEL provided a framework to identify important screening barriers among participants,28 and the Social Learning Theory29 and the Transtheoretical Model30 guided the educational program design and framing of the targeted messages. The Communication-Behavior Change Model and the Minority Health Communication Model focused on issues associated with delivering culturally appropriate health education for African Americans and Native Americans.31,32

Intervention development and implementation

The goal of the intervention was to increase awareness of the benefits of early detection of breast cancer and to encourage women of all racial groups to reduce their own risk of breast cancer mortality by identifying and reducing important barriers to obtaining mammography screening. Three lay health advisors (LHAs), two Native Americans and one African American, all women who lived in the community, were used for the project. The LHAs received training over a 1-week period by the study team members at Wake Forest University and local settings in Robeson County, with additional follow-up sessions throughout the study period. The LHA training included general project information, breast health information (breast cancer screening, diagnosis, treatment, and risk factors), administrative procedures (visits and telephone and mail contacts, study forms), practice intervention sessions, and a written examination. Problems or concerns with the interventions were addressed with the LHAs at weekly meetings, and the supervisor periodically attended home visits with each LHA to ensure protocol adherence in delivering the intervention.

The intervention was an individualized health education program that was tailored to the needs of each woman. The intervention consisted of three home visits with educational materials and follow-up phone calls and tailored mailings after each visit. The first visit (45–60 minutes) was conducted 2–4 weeks after completion of the baseline survey, and the focus of the visit was a detailed discussion about mammography, breast self-examination, breast cancer, and scheduling a mammogram. Visit two (30–45 minutes) was conducted 2–3 weeks after the first visit and reinforced the information from the first visit and addressed the woman’s barriers to completing mammography. Tailored phone calls and mailings were made during months 3–9 of the intervention to address any ongoing barriers and to encourage women to complete breast cancer screening. During the final visit (months 10–14), mammography screening was discussed along with reinforcing overall awareness of the importance of good breast health. Small gifts (calendars, coffee mugs) were given to the participants at this visit in appreciation of their time.

Participants were asked to complete a face-to-face follow-up survey that was similar to the baseline survey except that it asked about the intervention components to assess the value of the intervention and any contamination in the comparison group. Women who refused to complete the entire follow-up survey were asked to complete a shorter version of the survey. Ten percent of the women were recontacted by the assistant project manager to verify that the follow-up survey had been administered, and no problems were discovered. The control group received a mailing including a letter and a brochure focusing on cervical cancer screening from their physician 6 months after completing the baseline survey. Interviewers were blinded to intervention assignment of the women. A woman was defined as high risk for cervical cancer if she confirmed any of the following criteria on the baseline survey: (1) a history of being treated for a sexually transmitted disease (STD), (2) having present or previous sexual partners who had been treated for STDs, (3) engaging in sexual intercourse before 18 years of age, (4) having more than two sexual partners, or (5) ever smoking cigarettes on a regular basis. Risk-appropriate guidelines for cervical cancer screening are defined as a Pap test every year for women categorized as high risk, and every 3 years for women categorized as low risk for cervical cancer.33

Statistical analysis

There were 897 women eligible and randomized to one of the two study groups; 453 were in the intervention group, and 444 were randomized to the comparison group. The sample consisted of 295 African American women, 371 Native American women, and 226 white women, and 5 women were classified as being multiracial. The 5 multiracial women were excluded from the analyses so as to provide large cell counts and so that the study would focus on the three primary racial groups of interest. Of the 892 women, 41 moved, died, or were mentally/physically unable to complete the follow-up survey. Among the 851 (95.4%) women eligible for follow-up, 815 (95.8%) completed both baseline and follow-up surveys, which included information about Pap smear testing. Complete information for these analyses, which categorized women into high or low risk for developing cervical cancer, was available from 775 women (95%). Data for demographics, doctors’ encouragement for Pap screening, and risk factors were taken from the baseline survey, and Pap screening behavior was taken from both the baseline and follow-up surveys.

Frequencies and percentages of demographics, such as race, age, education, work status, marital status, private insurance, and whether or not a doctor ever recommended a Pap smear were calculated and compared between groups using chi-square tests or t tests. Frequencies and percentages were also calculated and compared between groups for each cervical cancer risk factor (ever treated for STD, any partners treated for STD, sexual intercourse before age 18, more than two sexual partners, and current or former smoker) and for women categorized as high risk for developing cervical cancer.

Risk-appropriate Pap screening rates were compared from baseline to follow-up using Mc-Nemar’s test because of paired data from each woman completing both surveys. These comparisons were made across the entire sample to determine if cervical cancer screening rates were higher at follow-up overall and separately by intervention group, racial group (African American, Native American, and white), and cervical cancer risk group (high/low).

Risk-appropriate Pap screening rates were also calculated by intervention group and survey for levels of each of the demographic factors, doctor recommendation for a Pap test, and risk factors. A logistic regression analysis with repeated measures was fit for each of these factors to test for a relationship between levels of that factor and Pap smear completion after adjusting for survey and intervention group. Odds ratios (OR) and standard errors (SE) comparing levels within each factor were computed from each model.

Predictive logistic regression modeling, with purposeful forward selection, was then used to determine the set of baseline demographic and other factors most predictive of risk-appropriate Pap screening after simultaneously adjusting for the other predictors in the model. Intervention group (intervention/comparison), survey (baseline/follow-up), cervical cancer risk group (high/low), and racial group were forced into the model, and generalized estimating equations (GEE) were used to account for the correlated data within subject across time. The model also included interaction effects for survey by intervention group to test if Pap test completion increased more in the intervention group than in the comparison group, and survey by cervical cancer risk group to test if Pap test completion varied differently according to cervical cancer risk group. Other two-way interactions were considered according to their statistical significance. All statistical tests were performed at a two-sided α = 0.05 level using the SAS System for Windows, version 9.1 (SAS Institute, Inc., Cary, NC).

RESULTS

The frequencies of demographic characteristics and doctor recommendation for a Pap smear from the baseline surveys of the 775 women are listed in Table 1. Thirty-two percent of the women were African American, 42% were Native American, and 25% were white. The average age was 54.95 years (SD = 11.1). Forty-four percent of the women never completed high school, and 43% reported working full or part time. Only 17% of the women were categorized as being High SES, which is defined by having a high school education, an income of at least $20,000, and private insurance. Nearly half (47%) of the women were married or living with partner, and 36% had private health insurance; 29% had no insurance at all. Sixty percent of the women reported that a Pap smear had not been recommended by their doctor. There were no statistically significant differences between the intervention and control groups in these variables at baseline.

Table 1.

Demographic Characteristics of Participants at Baseline by Treatment Groupsa

Variable Intervention (n = 387) Control (n = 388) Total (n = 775)
Race
 African American 125 (32%) 125 (32%) 250 (32%)
 Native American 163 (42%) 165 (43%) 328 (42%)
 White 99 (26%) 98 (25%) 197 (25%)
Age range (years)
 40–49 175 (45%) 161 (42%) 336 (43%)
 50–59 108 (28%) 105 (27%) 213 (28%)
 60–69 57 (15%) 70 (18%) 127 (16%)
 70+ 47 (12%) 51 (13%) 98 (13%)
Mean age: Years (SD) 54.39 (10.7) 55.52 (11.4) 54.95 (11.1)
Education
 <High school 165 (43%) 176 (45%) 341 (44%)
 High school 110 (28%) 128 (33%) 238 (31%)
 Some college 112 (29%) 84 (22%) 196 (25%)
Work status
 Work full-time/part-time 177 (46%) 157 (40%) 334 (43%)
 Retired 52 (13%) 45 (12%) 97 (13%)
 Homemaker 47 (12%) 61 (16%) 108 (14%)
 Unable/disability 95 (25%) 102 (26%) 197 (25%)
 Unemployed/other 16 (4%) 23 (6%) 39 (5%)
SESb
 Lower SES 311 (82%) 328 (85%) 639 (83%)
 High SES 70 (18%) 57 (15%) 127 (17%)
Marital status
 Married/living together 177 (46%) 185 (48%) 362 (47%)
 Divorced/separated 88 (23%) 85 (22%) 173 (22%)
 Widowed 91 (24%) 86 (22%) 177 (23%)
 Never married 31 (8%) 32 (8%) 63 (8%)
Insurance
 None 101 (27%) 122 (32%) 223 (29%)
 Not private 131 (35%) 132 (35%) 263 (35%)
 Private 147 (39%) 126 (33%) 273 (36%)
Doctor recommendation for Pap smear
 Yes 164 (42%) 148 (38%) 312 (40%)
 No 223 (58%) 240 (62%) 463 (60%)
a

No differences between the groups were statistically significant at the p < 0.05 level.

b

SES, socioeconomic status; High SES, high school graduate + annual income of at least $20,000 + private insurance.

Of the 815 participants completing baseline and follow-up surveys, 664 (85.7%) were categorized as being high risk for cervical cancer, 111 (14.3%) were low risk for cervical cancer, and 40 subjects could not be categorized because of “refused” or “don’t know” survey responses. Data on participants’ responses to the baseline survey regarding the criteria of high risk for cervical cancer categorization are provided in Table 2. Over half of the women (54%) reported having more than two sexual partners in their lifetime, and 51% had sexual intercourse before age 18. A little more than half (53%) of the women reported ever having smoked on a regular basis. Ten percent were ever treated for having an STD, and 7% had partners who had been treated for an STD. There were no statistically significant differences between the intervention and control groups in these risk factors.

Table 2.

Positive Responses to Criteria for Classification of Being High Risk for Cervical Cancer by Treatment Group and Overall

Criterion Intervention (n = 387) Control (n = 388) Total (n = 775)
Partner with treated STDa 30 (8%) 21 (6%) 51 (7%)
Treated STD 44 (11%) 31 (8%) 75 (10%)
Age <18 years at first sexual intercourse 196 (52%) 188 (50%) 384 (51%)
Current or former smoker 211 (55%) 200 (52%) 411 (53%)
>2 sexual partners 201 (57%) 177 (52%) 378 (54%)
High risk 335 (87%) 329 (85%) 664 (86%)
a

STD, sexually transmitted disease.

At the time of the baseline survey, 52.2% of all women were within risk-appropriate guidelines for a Pap smear. This rate significantly increased to 64.9% at follow-up (McNemar’s test, chi-square (1) = 38.42, p < 0.001) (Table 3). The percent of women within Pap smear guidelines increased in both the intervention and control groups and within each racial group. Whereas women in the high-risk group increased their Pap smear completion rate significantly (49% to 63%, McNemar’s test, chi-square (1) = 37.13, p = <0.001), women in the low-risk group did not significantly increase screening rates (73% to 77%, chi-square (1) = 1.33, p = 0.248).

Table 3.

Percent of Participants by Treatment Group, Race, and Cervical Cancer Risk Characterization within Risk-Appropriate Guidelines for Pap Testing at Baseline and Follow-Up Surveys (n = 775)

% within risk-appropriate guidelines for Pap testing
McNemar test
Baseline Follow-up Chi-square (1 df) p value
Overall treatment 52.2 64.9 38.42 <0.001
 Intervention 51.6 66.6 29.00 <0.001
 Control 52.9 63.2 11.94 <0.001
Race
 African American 55.0 66.7 10.65 0.001
 Native American 50.6 62.9 15.09 <0.001
 White 51.3 66.0 12.94 <0.001
Risk status
 Low risk 73.0 76.6 1.33 0.248
 High risk 48.7 62.9 37.13 <0.001

Table 4 displays the frequencies and percentages of women within risk-appropriate guidelines for Pap smear by intervention group and survey for each of the baseline demographic variables, doctor recommendation for Pap smear testing, and cervical cancer risk factors. Odds ratios are displayed for each factor after adjusting for intervention group and survey. There was a significant association between age and risk-appropriate Pap smear compliance (p < 0.001), with women 40–49 years old more likely to be within guidelines than older women. Additionally, women were significantly more likely to be within Pap smear screening guidelines if they were high school graduates or had some college (p < 0.001), were working part-time or full-time (p = 0.036), were categorized as high SES (p < 0.001), or had received a doctor’s recommendation for a Pap test (p = 0.010).

Table 4.

Odds Ratios Comparing Demographic Groups on Compliance with Risk-Appropriate Guidelines for Pap Testing by Treatment Groups (n = 775)

Variable Control baseline Control follow-up Intervention baseline Intervention follow-up OR (95% CI)
Race
 African American 62 (50%) 80 (64%) 75 (60%) 87 (70%) 1.10 (0.81, 1.51)
 Native American 91 (55%) 101 (62%) 74 (46%) 105 (64%) 0.92 (0.69, 1.24)
 Whitea 51 (52%) 64 (65%) 50 (51%) 66 (67%) 1.0
p = 0.458
Age range (years)
 40–49a 91 (57%) 103 (64%) 109 (62%) 129 (74%) 1.0
 50–59 52 (50%) 71 (68%) 47 (44%) 74 (69%) 0.74 (0.56, 0.98)
 60–69 39 (57%) 45 (65%) 28 (49%) 36 (63%) 0.79 (0.55, 1.12)
 70+ 22 (43%) 25 (49%) 15 (32%) 19 (40%) 0.38 (0.26, 0.57)
p = <0.001
Education
 <High schoola 83 (47%) 102 (58%) 72 (44%) 95 (58%) 1.0
 High school 71 (55%) 85 (66%) 61 (56%) 80 (73%) 1.57 (1.19, 2.07)
 Some college 50 (60%) 58 (69%) 66 (59%) 83 (74%) 1.79 (1.32, 2.42)
p = <0.001
Work status
 Homemaker 33 (54%) 37 (62%) 25 (54%) 32 (68%) 0.96 (0.66, 1.38)
 Retired 23 (52%) 23 (51%) 19 (37%) 24 (46%) 0.55 (0.37, 0.82)
 Unable/disability 53 (52%) 67 (66%) 48 (51%) 65 (68%) 0.94 (0.70, 1.26)
 Unemployed/other 14 (61%) 15 (65%) 12 (75%) 11 (69%) 1.33 (0.79, 2.27)
 Work full-time/part-timea 81 (52%) 103 (66%) 95 (54%) 126 (71%) 1.0
p = 0.036
SESb
 High SES 35 (61%) 45 (79%) 45 (64%) 53 (76%) 1.82 (1.29, 2.57)
 Lower SESa 167 (51%) 199 (61%) 151 (49%) 201 (65%) 1.0
p = <0.001
Marital status
 Divorced/separated 40 (47%) 48 (56%) 51 (58%) 69 (78%) 0.98 (0.72, 1.33)
 Married/living togethera 109 (59%) 128 (70%) 88 (50%) 112 (63%) 1.0
 Never married 13 (41%) 21 (66%) 18 (58%) 20 (65%) 0.87 (0.56, 1.33)
 Widowed 42 (49%) 48 (56%) 42 (47%) 57 (63%) 0.75 (0.55, 1.02)
p = 0.293
Insurance
 Nonea 61 (50%) 85 (70%) 48 (48%) 64 (63%) 1.0
 Not private 63 (48%) 74 (56%) 66 (50%) 83 (63%) 0.87 (0.65, 1.17)
 Private 77 (61%) 85 (67%) 81 (55%) 107 (73%) 1.31 (0.97, 1.77)
p = 0.019
Doctor recommended
 Noa 118 (49%) 142 (59%) 112 (50%) 141 (63%) 1.0
 Yes 86 (59%) 103 (70%) 87 (53%) 117 (71%) 1.37 (1.08, 1.75)
p = 0.010
More than 2 sexual partners
 Noa 89 (54%) 103 (63%) 83 (54%) 102 (67%) 1.0
 Yes 94 (53%) 113 (64%) 99 (50%) 138 (69%) 0.98 (0.76, 1.26)
p = 0.854
<18 at first sexual intercourse
 Noa 114 (61%) 123 (65%) 99 (54%) 131 (72%) 1.0
 Yes 84 (45%) 115 (61%) 95 (49%) 122 (62%) 0.70 (0.55, 0.89)
p = 0.003
Ever smoked
 Noa 104 (56%) 123 (65%) 101 (57%) 125 (71%) 1.0
 Yes 100 (50%) 122 (61%) 98 (47%) 133 (63%) 0.74 (0.58, 0.94)
p = 0.014
Ever treated for STD
 Noa 189 (53%) 225 (64%) 177 (52%) 230 (67%) 1.0
 Yes 13 (42%) 19 (61%) 22 (50%) 28 (64%) 0.83 (0.58, 1.20)
p = 0.328
Any partners treated for STD
 Noa 192 (54%) 228 (64%) 182 (52%) 235 (67%) 1.0
 Yes 8 (38%) 13 (62%) 13 (43%) 19 (63%) 0.74 (0.47, 1.15)
p = 0.184
Risk
 Higha 163 (50%) 201 (61%) 159 (48%) 217 (65%) 1.0
 Low 41 (69%) 44 (75%) 40 (77%) 41 (79%) 2.41 (1.59, 3.68)
p = <0.001
a

Referent category.

b

SES, socioeconomic status; High SES, high school graduate + annual income of at least $20,000 + private insurance.

Individual risk factors for cervical cancer were associated with being within risk-appropriate Pap screening guidelines. Women who had their first sexual intercourse before age 18 were less likely to be within guidelines (p = 0.003) as were women who had ever smoked cigarettes on a regular basis (p = 0.014) compared with nonsmokers. Women who were categorized as low risk were much more likely to be within risk-appropriate Pap guidelines (p < 0.001) compared with women at high risk for developing cervical cancer.

The final logistic regression model included factors for survey, intervention group, risk for cervical cancer, survey and intervention group, survey and risk for cervical cancer, and race (all forced into the model) along with age group, doctor’s recommendation for Pap test, SES, doctor’s recommendation and SES, and doctor’s recommendation and age group (selected for their predictive ability). Thirteen women had missing data for one or more covariates (assumed missing at random); thus, data from 762 women were included in the final model. The significance of each effect along with resulting ORs are displayed in Table 5. The odds of Pap smear completion within guidelines where higher at the follow-up survey than at the baseline survey for women in both the intervention group (p < 0.001) and the control group (p = 0.025), but this OR was not significantly different for women in the intervention group than women in the control group (p = 0.244). The odds of being within guidelines increased from baseline to follow-up in the high risk for cervical cancer group (p < 0.001) significantly more than in the low risk for cervical cancer group (p = 0.221), as evidenced by a marginally significant interaction between cervical cancer risk group and survey (p = 0.065). The odds of Pap test compliance decreased with each successive age group compared to 40–49 year olds. A doctor’s recommendation to have a Pap smear was associated with increased odds of Pap smear completion (p = <0.001), and odds were also increased for women in the high SES group compared with those in the low SES group (p = 0.013). The effect of the doctor’s recommendation was significantly higher (p = 0.002) in the high SES group (p = <0.001) than in the low SES group (p = 0.028), and it had the largest effect in the group of women at least 70 years old (p < 0.001). Each of these ORs represent the odds after adjusting for all the other factors in the model.

Table 5.

Predictors of Pap Screening within Risk-Appropriate Guidelines and Their Significance from Final Multivariable Logistic Regression Model Along with Relevant Odds Ratios from Model (n = 762)

Effect DF Chi-square Pr > ChiSqa Comparison Within group OR (95% CI) p valueb
Race 2 1.37 0.5040 African American vs. white 1.16 (0.83, 1.62) 0.392
Native American vs. white 0.98 (0.72, 1.34) 0.910
Survey 1 13.72 0.0002 Follow-up vs. baseline 1.53 (1.25, 1.88) <0.001
Treatment 1 0.06 0.8129 Intervention vs. control 1.03 (0.80, 1.32) 0.813
Survey × treatment 1 1.36 0.2437 Follow-up vs. baseline Control group 1.38 (1.04, 1.82) 0.025
Intervention group 1.70 (1.31, 2.21) <0.001
Risk 1 26.60 <0.0001 Low risk vs. high risk 3.05 (1.97, 4.74) <0.001
Survey × risk 1 3.41 0.0648 Follow-up vs. baseline High risk 1.88 (1.54, 2.28) <0.001
Low risk 1.25 (0.87, 1.79) 0.221
Doctor recommendation 1 18.37 <0.0001 Doctor recommendation: Yes vs. no. 2.54 (1.66, 3.87) <0.001
SES 1 6.62 0.0101 High SES vs. low SES 1.63 (1.11, 2.41) 0.013
Doctor recommendation × SES 1 9.81 0.0017 Doctor recommendation: Yes vs. no. High SES 4.64 (2.19, 9.86) <0.001
Low SES 1.39 (1.04, 1.86) 0.028
Age group 3 22.71 <0.0001 50–59 vs. 40–49 0.86 (0.64, 1.17) 0.347
60–69 vs. 40–49 0.73 (0.51, 1.05) 0.094
70+ vs. 40–49 0.32 (0.20, 0.49) <0.001
Doctor recommendation × age group 3 19.06 0.0003 Doctor recommendation: Yes vs. no. Ages 40–49 1.53 (0.98, 2.39) 0.062
Ages 50–59 3.62 (2.07, 6.33) <0.001
Ages 60–69 1.18 (0.59, 2.37) 0.638
Ages 70+ 6.33 (2.75, 14.6) <0.001
a

Score statistics for type 3 GEE analysis.

b

All p values are unadjusted for multiple hypothesis tests. The primary hypothesis is for the interaction of survey and treatment group along with the ORs for screening at follow-up vs. baseline for each treatment group, and other p values may be considered exploratory.

DISCUSSION

There was a significant increase in the receipt of cervical cancer screening within guidelines among women who participated in the ROSE Project, originally designed to increase mammography screening rates among women in need of a mammogram. This increase in cervical cancer screening was documented in women randomly assigned to both the intervention and control groups, with no significant difference in these rates between groups at the follow-up survey. Additionally, cervical cancer screening within guidelines was increased at the follow-up survey in all three racial groups.

It is interesting to note, however, that although there was no significant increase in cervical cancer screening in women at low risk for cervical cancer (73.0% to 76.6%, p = 00.248), there was a significant increase among women at high risk for cervical cancer at the follow-up survey (48.7% to 62.9%, p < 0.001). Women categorized as high risk for cervical cancer were less likely to be screened within risk-appropriate guidelines at the baseline survey (48.7%) compared with women at low risk for cervical cancer (73.0%). Women in this study who were at high risk may not have been aware of the need to be screened annually, were less adherent to healthy behaviors, did not have the time, or might not have been able to complete the annual tests due to financial constraints.25,33

Predictors of the receipt of a Pap test in the present study were similar to those identified in previous studies conducted among different racial, SES, and cultural groups.3444 These factors include a physician’s recommendation for a Pap test,37,40 younger age,42,44 and higher SES group.34,40,41,42,44 Insurance status was not significantly associated with the receipt of a Pap test within guidelines, whereas previous studies have found an association.34,35,37,39,4244 The present study, however, did not examine the impact of beliefs and knowledge about Pap tests on Pap smear completion.

The LHA intervention tested in this study specifically focused on improving knowledge about, reducing barriers to, and providing social support for mammography.26 The intervention did not focus specifically on Pap test completion, but as the LHA sessions are flexible, this topic may have been addressed. Additionally, the sessions may have provided the women with overall health awareness and empowerment skills. The brochure and letter were a more traditional behavioral approach, addressing knowledge and physician recommendation for cervical cancer screening.4547

Behavioral interventions designed to increase rates of one cancer screening test, especially those delivered by an LHA, provide a teachable moment to discuss being within risk-appropriate guidelines for all cancer screening tests. Previous studies testing interventions designed to increase multiple cancer screening behaviors have focused mostly on increasing breast and cervical cancer screening.113 These interventions have been conducted in clinics, worksites, the community, and the participants’ homes. The interventions were delivered by LHAs, especially in minority populations, but some interventions were also provided by nurses, community-based coalition members, and counselors. The research designs of these studies have varied, making the results of the different intervention strategies difficult to compare. Most interventions, however, demonstrated an increase in cancer screening completion rates.

The belief that an individual will adopt multiple health behaviors by specifically addressing only one health behavior has not been thoroughly investigated. The results of this study demonstrate that increasing awareness of different preventive health behaviors in an intervention directed at a specific behavior may prove to be worth the small additional effort. In a previous study, self-efficacy in changing one risk behavior (smoking) was significantly related to self-efficacy change in another behavior (exercise).46 This suggests that an individual’s attitude or confidence about changing one behavior may be associated either simultaneously or sequentially with another behavior. Although potentially practical, more studies specifically addressing multiple cancer screening tests must be conducted in the future before a definitive recommendation can be made about this complex behavioral and logistic relationship. Based on this study, recalcitrant women (approximately 30% of the study population who did not receive a Pap smear) may need more intensive interventions focusing on cervical cancer to increase Pap smear screening rates.

This study has several strengths. This was a randomized trial of underserved women belonging to three racial groups who lived in a rural county in North Carolina. In addition, 95% of the women who completed the baseline survey were eligible for the follow-up survey, and the response rate for the follow-up survey was 95%. A limitation of this study is that it was based on women’s self-report of Pap tests, which has been shown to vary in accuracy compared with medical records.4750 As no intervention effect was found, however, there is no reason to believe that participants in the intervention arm biased reporting of Pap test completion at follow-up. Additionally, awareness of Pap testing may have been raised among women because of questions about Pap test completion on the baseline survey. The frequency of discussion about cervical cancer screening during the LHA visits was not documented, and this may have influenced the increased rate of Pap test completion in the intervention group. Although the increase in cervical screening may have been due to a secular trend, the Behavioral Risk Factor Surveillance System (BRFSS) data suggest that the cervical screening rates did not change during the period of the study. Pap test rates were low at both baseline (52.5%) and follow-up (65.2%) in this study compared with the 68% rate from the BRFSS for women 40+ years in the United States during that same time period51; thus, this group of women was in need of interventions for cervical cancer screening. Finally, the clinic patients included in this study may not represent all women in the United States, as they were from a federally qualified health center, and all women needed a mammogram.

In conclusion, this study describes the cervical cancer screening behaviors of women participating in an intervention designed to increase mammography rates. The results of this study suggest that it might be beneficial to address multiple cancer screening tests in behavioral interventions. Although the results of this study are supportive of addressing multiple behaviors, the increased burden of changing multiple behaviors needs further exploration. Future theoretical research and intervention studies should address the behavioral and logistic ramifications of improving multiple cancer screening test rates simultaneously.

Acknowledgments

This research was supported by grants CA72022-04 and CA57707-08 from the National Cancer Institute, National Institutes of Health.

References

  • 1.Paskett ED, Tatum CM, D’Agostino R, et al. Community-based interventions to improve breast and cervical cancer screening: Results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer Epidemiol Biomarkers Prev. 1999;8:453. [PubMed] [Google Scholar]
  • 2.Eaker ED, Jaros L, Vierkant RA, Lantz P, Remington PL. Women’s health alliance intervention study: Increasing community breast and cervical cancer screening. Public Health Management Practice. 2001;7:20. doi: 10.1097/00124784-200107050-00004. [DOI] [PubMed] [Google Scholar]
  • 3.Allen JD, Stoddard AM, Mays J, Sorensen G. Promoting breast and cervical cancer screening at the workplace: Results from the Woman to Woman Study. Am J Public Health. 2001;91:584. doi: 10.2105/ajph.91.4.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Margolis KL, Lurie N, McGovern PG, Tyrrell M, Slater JS. Increasing breast and cervical cancer screening in low-income women. J Gen Intern Med. 1998;13:515. doi: 10.1046/j.1525-1497.1998.00161.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Burack RC, Gimotty PA, Simon M, Moncrease A, Dews P. The effect of adding Pap smear information to a mammography reminder system in an HMO: Results of randomized controlled trial. Prev Med. 2003;36:547. doi: 10.1016/s0091-7435(02)00062-2. [DOI] [PubMed] [Google Scholar]
  • 6.Valanis B, Whitlock EE, Mullooly J, et al. Screening rarely screened women: Time-to-service and 24-month outcomes of tailored interventions. Prev Med. 2003;37:442. doi: 10.1016/s0091-7435(03)00165-8. [DOI] [PubMed] [Google Scholar]
  • 7.Navarro AM, Senn KL, McNicholas LJ, Kaplan RM, Roppe B, Campo MC. Por La Vida model intervention enhances use of cancer screening tests among Latinas. Am J Prev Med. 1998;15:32. doi: 10.1016/s0749-3797(98)00023-3. [DOI] [PubMed] [Google Scholar]
  • 8.Maxwell AE, Bastani R, Vida P, Warda US. Results of a randomized trial to increase breast and cervical cancer screening among Filipino American women. Prev Med. 2003;37:102. doi: 10.1016/s0091-7435(03)00088-4. [DOI] [PubMed] [Google Scholar]
  • 9.Ansell D, Lacey L, Whitman S, Chen E, Phillips C. A nurse-delivered intervention to reduce barriers to breast and cervical cancer screening in Chicago inner city clinics. Public Health Rep. 1994;109:104. [PMC free article] [PubMed] [Google Scholar]
  • 10.Hansen LK, Feigl P, Modiano MR, et al. An educational program to increase cervical and breast cancer screening in Hispanic women: A Southwest Oncology Group Study. Cancer Nurs. 2005;28:47. doi: 10.1097/00002820-200501000-00007. [DOI] [PubMed] [Google Scholar]
  • 11.Mandelblatt J, Traxler M, Lakin P, et al. A nurse practitioner intervention to increase breast and cervical cancer screening for poor, elderly black women. The Harlem Study Team. J Gen Intern Med. 1993;8:173. doi: 10.1007/BF02599260. [DOI] [PubMed] [Google Scholar]
  • 12.Sung JF, Blumenthal DS, Coates RJ, Williams JE, Alema-Mensah E, Liff JM. Effect of a cancer screening intervention conducted by lay health workers among inner-city women. Am J Prev Med. 1997;13:51. [PubMed] [Google Scholar]
  • 13.Williams RB, Boles M, Johnson RE. A patient-initiated system for preventive health care. A randomized trial in community-based primary care practices. Arch Fam Med. 1998;7:338. doi: 10.1001/archfami.7.4.338. [DOI] [PubMed] [Google Scholar]
  • 14.Jeffery RW, Forster JL, French SA, et al. The healthy worker project: A worksite intervention for weight control and smoking cessation. Am J Public Health. 1993;83:395. doi: 10.2105/ajph.83.3.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Emmons KM, Marcus BH, Linnan L, Rossi JS, Abrams DB. Mechanisms in multiple risk factor interventions: Smoking, physical activity, and dietary fat intake among manufacturing workers. Prev Med. 1994;23:481. doi: 10.1006/pmed.1994.1066. [DOI] [PubMed] [Google Scholar]
  • 16.Emmons KM, Linnan L, Shadel WG, Marcus B, Abrams DB. The Working Healthy Project: A work-site health-promotion trial targeting physical activity, diet, and smoking. J Occup Environ Med. 1999;41:545. doi: 10.1097/00043764-199907000-00003. [DOI] [PubMed] [Google Scholar]
  • 17.Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for smoking cessation in women: A randomized controlled trial. Arch Intern Med. 1999;159:1229. doi: 10.1001/archinte.159.11.1229. [DOI] [PubMed] [Google Scholar]
  • 18.Pirie PL, Lando H, Curry SJ, McBride CM, Grothaus LC. Tobacco, alcohol, and caffeine use and cessation in early pregnancy. Am J Prev Med. 2000;18:54. doi: 10.1016/s0749-3797(99)00088-4. [DOI] [PubMed] [Google Scholar]
  • 19.Pirie PL, McBride CM, Hellerstedt W, et al. Smoking cessation in women concerned about weight. Am JPublic Health. 1992;82:1238. doi: 10.2105/ajph.82.9.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Campbell MK, Tessaro I, DeVellis B, et al. Tailoring and targeting a worksite health promotion program to address multiple health behaviors among blue-collar women. Am J Health Promotion. 2000;14:306. doi: 10.4278/0890-1171-14.5.306. [DOI] [PubMed] [Google Scholar]
  • 21.Prochaska JJ, Sallis JF. A randomized controlled trial of single versus multiple health behavior change: Promoting physical activity and nutrition among adolescents. Health Psychol. 2004;23:314. doi: 10.1037/0278-6133.23.3.314. [DOI] [PubMed] [Google Scholar]
  • 22.Hall SM, Tunstall CD, Vila KL, Duffy J. Weight gain prevention and smoking cessation: Cautionary findings. Am J Public Health. 1992;82:799. doi: 10.2105/ajph.82.6.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ory MG, Jordan PJ, Bazzarre The behavior change consortium: Setting the stage for a new century of health behavior-change research. Health Educ Res. 2002;17:500. doi: 10.1093/her/17.5.500. [DOI] [PubMed] [Google Scholar]
  • 24.Nigg CR, Allegrante JP, Ory M. Theory-comparison and multiple-behavior research: Common themes advancing health behavior research. Health Educ Res. 2002;17:670. doi: 10.1093/her/17.5.670. [DOI] [PubMed] [Google Scholar]
  • 25.Paskett ED, Tatum C, Rusing J, et al. Racial differences in knowledge, attitudes and cancer screening practices among a triracial rural population. Cancer. 2004;101:2650. doi: 10.1002/cncr.20671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Paskett ED, Tatum C, Rushing J, et al. Randomized controlled trial to improve mammography utilization among a tri-ethnic rural population of women. J Natl Cancer Inst. 2006;98:1226. doi: 10.1093/jnci/djj333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.U.S. Department of Commerce, Bureau of the Census. United States Census 2000. Washington, DC: U.S. Government Printing Office; 2001. [Google Scholar]
  • 28.Green LW, Kreuter MW. Health promotion planning. An educational and ecological approach. 3. New York: McGraw-Hill Companies, Inc; 1999. [Google Scholar]
  • 29.Baranowski T, Perry CL, Parcel GS. Social cognitive theory. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education. Theory, research, and practice. 3. San Francisco, CA: Jossey-Bass; 2002. p. 165. [Google Scholar]
  • 30.Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39. doi: 10.1037//0278-6133.13.1.39. [DOI] [PubMed] [Google Scholar]
  • 31.Alcalay R. Rationale and guidelines for developing a minority health communication model. 1980 May; Unpublished manuscript prepared for NCI. [Google Scholar]
  • 32.McGuire WJ. Public communication as a strategy for inducing health-promoting behavior change. Prev Med. 1984;13:299. doi: 10.1016/0091-7435(84)90086-0. [DOI] [PubMed] [Google Scholar]
  • 33.Cyrus-David M, Michielutte R, Paskett E, D’Agostino R, Goff D. Cervical cancer risk as a predictor of Pap smear use in rural North Carolina. J Rural Health. 2002;18:67. doi: 10.1111/j.1748-0361.2002.tb00878.x. [DOI] [PubMed] [Google Scholar]
  • 34.Yabroff KR, Lawrence WF, King JC, et al. Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment? J Rural Health. 2005;21:149. doi: 10.1111/j.1748-0361.2005.tb00075.x. [DOI] [PubMed] [Google Scholar]
  • 35.Somkin CP, McPhee SJ, Nguyen T, et al. The effect of access and satisfaction on regular mammogram and Papanicolaou test screening in a multiethnic population. Med Care. 2004;42:914. doi: 10.1097/01.mlr.0000135832.28672.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Amonkar MM, Madhavan S. Compliance rates and predictors of cancer screening recommendations among Appalachian women. J Health Care Poor Underserved. 2002;13:443. doi: 10.1353/hpu.2010.0582. [DOI] [PubMed] [Google Scholar]
  • 37.Ogedegbe G, Cassells AN, Robinson CM, et al. Perceptions of barriers and facilitators of cancer early detection among low-income minority women in community health centers. J Natl Med Assoc. 2005;97:162. [PMC free article] [PubMed] [Google Scholar]
  • 38.Hewitt M, Devesa S, Breen N. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: Analyses of the 1995 National Survey of Family Growth. Am J Public Health. 2002;92:666. doi: 10.2105/ajph.92.4.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: Analyses of the 2000 National Health Interview Survey. Prev Med. 2004;39:270. doi: 10.1016/j.ypmed.2004.03.035. [DOI] [PubMed] [Google Scholar]
  • 40.Bazargan M, Bazargan SH, Farooq M, Baker RS. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med. 2004;39:465. doi: 10.1016/j.ypmed.2004.05.003. [DOI] [PubMed] [Google Scholar]
  • 41.Simoes EJ, Newschaffer CJ, Hagdrup N, et al. Predictors of compliance with recommended cervical cancer screening schedule: A population-based study. J Community Health. 1999;24:115. doi: 10.1023/a:1018754307718. [DOI] [PubMed] [Google Scholar]
  • 42.Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: Evidence from the Women’s Health Initiative. Prev Med. 2000;31:261. doi: 10.1006/pmed.2000.0697. [DOI] [PubMed] [Google Scholar]
  • 43.Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528. doi: 10.1002/cncr.11208. [DOI] [PubMed] [Google Scholar]
  • 44.Selvin E, Brett KM. Breast and cervical cancer screening: Sociodemographic predictors among white, black, and Hispanic women. Am J Public Health. 2003;93:618. doi: 10.2105/ajph.93.4.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Marcus AC, Crane LA. A review of cervical cancer screening intervention research: Implications for public health programs and future research. Prev Med. 1998;27:13. doi: 10.1006/pmed.1997.0251. [DOI] [PubMed] [Google Scholar]
  • 46.Meissner HI, Breen N, Coyne C, Legler JM, Green DT, Edwards BK. Breast and cervical cancer screening interventions: An assessment of the literature. Cancer Epidemiol Biomarkers Prev. 1998;7:951. [PubMed] [Google Scholar]
  • 47.Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev. 1996;5:721. [PubMed] [Google Scholar]
  • 48.Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85:566. doi: 10.1093/jnci/85.7.566. [DOI] [PubMed] [Google Scholar]
  • 49.Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev. 2003;12:1182. [PubMed] [Google Scholar]
  • 50.Bowman JA, Sanson-Fisher R, Redman S. The accuracy of self-reported Pap smear utilization. Soc Sci Med. 1997;44:969. doi: 10.1016/s0277-9536(96)00222-5. [DOI] [PubMed] [Google Scholar]
  • 51.Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1996. [Google Scholar]

RESOURCES